These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 15541604

  • 21. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y, Chen L, Li C.
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [Abstract] [Full Text] [Related]

  • 22. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [Abstract] [Full Text] [Related]

  • 23. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
    Chen YC, Chang SC, Luh KT, Hsieh WC.
    J Antimicrob Chemother; 2003 Jul; 52(1):71-7. PubMed ID: 12775680
    [Abstract] [Full Text] [Related]

  • 24. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E, Bilgen H, Cerikçioğlu N, Ilki A, Ulger N, Bakır M, Akman I, Ozek E.
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [Abstract] [Full Text] [Related]

  • 25. A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion.
    Liebowitz LD, Ashbee HR, Evans EG, Chong Y, Mallatova N, Zaidi M, Gibbs D, Global Antifungal Surveillance Group.
    Diagn Microbiol Infect Dis; 2001 Oct; 40(1-2):27-33. PubMed ID: 11448560
    [Abstract] [Full Text] [Related]

  • 26. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
    Kronvall G, Karlsson I.
    J Clin Microbiol; 2001 Apr; 39(4):1422-8. PubMed ID: 11283066
    [Abstract] [Full Text] [Related]

  • 27. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 28. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
    Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD.
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E.
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [Abstract] [Full Text] [Related]

  • 30. Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method.
    Colombo AL, Da Matta D, De Almeida LP, Rosas R.
    Braz J Infect Dis; 2002 Jun; 6(3):118-23. PubMed ID: 12144747
    [Abstract] [Full Text] [Related]

  • 31. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY, Tan AL, Tee NW, Ng LS, Chee CW.
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [Abstract] [Full Text] [Related]

  • 32. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.
    Rev Argent Microbiol; 2001 Nov; 33(4):217-22. PubMed ID: 11833253
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
    Wang JL, Chang SC, Hsueh PR, Chen YC.
    J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM, Weikert-Oliveira Rde C, Lyon JP, Cury VF, Arantes RR, Koga-Ito CY, Resende MA.
    Microbiol Res; 2008 Aug; 163(5):579-85. PubMed ID: 16962755
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.